Search is Powered by Google
Breast Cancer News

Side Effects Could Cause Women To Stop Taking Drugs Aimed At Preventing Breast Cancer Recurrence, Studies Say

Main Category: Breast Cancer
Also Included In: Compliance;  Women's Health / Gynecology
Article Date: 12 Sep 2007 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (4 votes)

Health Professional:4 stars

4 (1 votes)

Article Opinions: 0 posts

Some women taking the drugs tamoxifen and aromatase inhibitors, which block the production of estrogen, to prevent breast cancer recurrence are ending their therapy prematurely because of side effects, according to two studies presented Thursday at the 2007 Breast Cancer Symposium in San Francisco, Reuters reports.

For one study, Alastair Thompson of the University of Dundee in Scotland and colleagues examined the records of 2,080 women treated for breast cancer between 1993 and 2002. The women in the study took tamoxifen for an average of just under 2.5 years to help prevent breast cancer recurrence. Tamoxifen is shown to be most effective if taken for five years, Reuters reports. According to the study, 10% of the women failed to fill 30% or more of their tamoxifen prescriptions. These women were 16% more likely to die during the study period than women who remained on their tamoxifen regimens as directed, the study found. "It could well be a question of side effects," Thompson said, adding, "I think most women who take tamoxifen know that it does have very substantial and life-affecting side effects, even if just hot flashes, which can make life a misery."

In the second study, Lynn Henry of the University of Michigan Comprehensive Cancer Center enrolled 100 women in a trial comparing two different aromatase inhibitors. The study showed that 13% of women taking an aromatase inhibitor requested to be taken off the drug because of muscle aches. Twenty-three percent of the 100 women dropped out of the trial, Henry said. "The vast majority of patients are switching to something else," she said, adding, "They understand that they still need to have their breast cancer treated" (Fox, Reuters, 9/6).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Ad Banner - the most access to the best resources


Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar

Sign up to receive newsletters / news alerts
MedReader RSS Reader


Breast Cancer Clinical Trials image Breast Cancer Clinical Trials

There are now a wide variety of treatment options for breast cancer. How do you make sense of them all? Learn what experts have to say about the newest research and how it can affect you...

Breast Cancer Recurrence image Breast Cancer Recurrence

Women and their doctors sometimes have different perspectives on the treatment for breast cancer. Listen to experts discuss treatment goals and the impact these have on daily life...

View more videos...